PUBLICATIONS · 27211272
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Leukemia
- Publication date
- 2016 Aug
- First author
- Harrison CN
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Leukemia. 2017 Mar;31(3):775. doi: 10.1038/leu.2016.323.
- note
- Source null
- related pmid
- 28248313
- relationship
- Erratum in
Authors and identifiers
- name
- Harrison CN
- type
- Author
- name
- Vannucchi AM
- type
- Author
- name
- Kiladjian JJ
- type
- Author
- name
- Al-Ali HK
- type
- Author
- name
- Gisslinger H
- type
- Author
- name
- Knoops L
- type
- Author
- name
- Cervantes F
- type
- Author
- name
- Jones MM
- type
- Author
- name
- Sun K
- type
- Author
- name
- McQuitty M
- type
- Author
- name
- Stalbovskaya V
- type
- Author
- name
- Gopalakrishna P
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Harrison CN
- type
- Author
- name
- Vannucchi AM
- type
- Author
- name
- Kiladjian JJ
- type
- Author
- name
- Al-Ali HK
- type
- Author
- name
- Gisslinger H
- type
- Author
- name
- Knoops L
- type
- Author
- name
- Cervantes F
- type
- Author
- name
- Jones MM
- type
- Author
- name
- Sun K
- type
- Author
- name
- McQuitty M
- type
- Author
- name
- Stalbovskaya V
- type
- Author
- name
- Gopalakrishna P
- type
- Author
- bibliography ids
- nci-bib-cfc48b0c4dd802cd6c4a9deb
- book metadata
- content sha256
- 2e730ac5fc3f8644d92aa7406ded9bdd0d358db69e38ceb32078cbb3fd6fa88d
- document type
- citation
- dois
- 10.1038/leu.2016.148
- electronic publication date
- display
- 2016 May 23
- precision
- day
- year
- 2016
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:27211272
- immutable id
- pubmed:27211272@2e730ac5fc3f8644d92aa7406ded9bdd0d358db69e38ceb32078cbb3fd6fa88d
- journal
- abbreviation
- Leukemia
- issn electronic
- 1476-5551
- issn print
- 0887-6924
- issue
- 8
- name
- Leukemia
- nlm unique id
- 8704895
- pages
- 1701-7
- volume
- 30
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Leukemia. 2017 Mar;31(3):775. doi: 10.1038/leu.2016.323.
- note
- Source null
- related pmid
- 28248313
- relationship
- Erratum in
- outcomes validated
- false
- pmid
- 27211272
- provenance
- batch id
- fe5a46c92522c34737e8
- provider
- NCBI PubMed ESummary
- record sha256
- adc82996a115292c69b3977cfa38ffcd2d87f7d17007d9da570b36f7b9498e05
- response sha256
- 2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
- retrieved at
- 2026-09-09T23:47:17.939307+00:00
- publication date
- display
- 2016 Aug
- precision
- month
- year
- 2016
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis.
Preserved source evidence · Not medical advice
Triangle